Overview of Molecular Prognostication for Common Solid Tumor Histologies - What the Surgeon Should Know
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Molecular markers and targeted therapies significantly improve survival for common cancers metastasizing to the spine. Integrating these advancements into clinical decisions enhances patient outcomes for metastatic spine disease.
Area Of Science
- Oncology
- Molecular Biology
- Spine Surgery
Background
- Metastatic spine disease is a common complication of several major cancers.
- Molecular markers and targeted therapies have revolutionized cancer treatment and survival rates.
- Understanding these advancements is crucial for managing spinal metastases.
Purpose Of The Study
- To review key molecular markers and targeted therapies for lung, breast, prostate, and melanoma cancers that metastasize to the spine.
- To provide guidance on integrating these therapies into clinical practice for spinal metastases.
- To highlight the role of molecular prognostication in surgical decision-making.
Main Methods
- A narrative literature review was conducted using PubMed, Google Scholar, and Medline.
- National Comprehensive Cancer Network guidelines were also consulted.
- Articles were selected in English and reviewed for molecular targets, therapies, outcomes, and surgical risks.
Main Results
- Molecular markers and targeted therapies have substantially improved cancer patient survival.
- These advancements offer a strong rationale for their use in clinical decision-making for metastatic spine disease.
- The review discusses specific markers and therapies for common spinal metastases and offers a surgical decision-making framework.
Conclusions
- An integrated approach considering surgery, radiation, molecular markers, and targeted therapies is essential.
- This integrated understanding guides prognostication and treatment for better patient outcomes.
- Optimizing outcomes for metastatic spine disease requires a comprehensive treatment strategy.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...